SCHEMBL5586762

SCHEMBL5586762

CCCCCCc1c(CCCCCC)c(OOC)c(O)c(C(=O)O)c1CCCCCC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 4/20 0.41
BID P55957 3/20 0.40
MCL1 Q07820 3/20 0.40
KAT8 Q9H7Z6 3/20 0.40
PPARG P37231 3/20 0.40
BCL2L1 Q07817 2/20 0.40
BAK1 Q16611 2/20 0.40
EP300 Q09472 2/20 0.40
KAT5 Q92993 2/20 0.40
SAE1 Q9UBE0 2/20 0.40
KAT2A Q92830 1/20 0.40
KAT2B Q92831 1/20 0.40
ALOX5 P09917 5/20 0.40
PPARD Q03181 1/20 0.39
PTPN1 P18031 1/20 0.37
PTGES O14684 1/20 0.36
MMP2 P08253 2/20 0.36
KDM4E B2RXH2 1/20 0.36
F7 P08709 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5589328 1.00 PPARA (0.41) PPARABIDMCL1KAT8PPARG
SCHEMBL5588229 1.00 PPARA (0.41) PPARABIDMCL1KAT8PPARG
SCHEMBL5589964 1.00 PPARA (0.41) PPARABIDMCL1KAT8PPARG
SCHEMBL5587404 0.99 PPARA (0.40) PPARABIDMCL1KAT8PPARG
SCHEMBL5586932 0.94 FFAR1 (0.38) PPARABIDMCL1KAT8PPARG
SCHEMBL5587856 0.92 ALOX5 (0.44) PPARABIDMCL1KAT8PPARG
SCHEMBL5590171 0.92 ALOX5 (0.44) PPARABIDMCL1KAT8PPARG
SCHEMBL5587081 0.92 ALOX5 (0.44) PPARABIDMCL1KAT8PPARG
SCHEMBL5589535 0.92 ALOX5 (0.44) PPARABIDMCL1KAT8PPARG
SCHEMBL5588630 0.92 ALOX5 (0.44) PPARABIDMCL1KAT8PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 PPARA 2921/4885BID 1517/4885MCL1 1660/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.